Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
---|
09/09/2004 | US20040176417 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
09/09/2004 | US20040176409 treating or preventing a metabolic disorder or an inflammatory condition; modulate the PPAR gamma receptor; diagnosis and treatment of: type II diabetes, hypercholesterolemia, and inflammatory disorders |
09/09/2004 | US20040176385 treating cancer by inhibiting phosphotidylinositol 3-kinase; in combination with other known agents to modulate cellular proliferation |
09/09/2004 | US20040176377 inhibitors of glycogen synthase kinase-3 beta; treatment of diabetes or neurodegenerative diseases such as Alzheimer's disease; 6-(2-butylamino-pyrimidin-4-yl)-3-oxo-2,3-dihydro-pyridazine-4-carboxylic acid (3-pyridin-3-yl-propyl)-amide, as example |
09/09/2004 | US20040176374 Arylsulfonamides as antiviral agents |
09/09/2004 | US20040176364 Aryl substituted thiazinidinones and the use thereof |
09/09/2004 | US20040176363 N-Acylpiperazine derivatives; cardiovascular disorders; anticoagulants |
09/09/2004 | US20040176355 Melanin-concentrating hormone antagonists for eating disorder and diabetes treatment |
09/09/2004 | DE10306250A1 Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted N-Arylheterozyklen, processes for their preparation and their use as medicaments |
09/08/2004 | EP1454907A1 Quninazoline and pyridopyrmidine derivatives |
09/08/2004 | EP1454902A1 N- (substituted five-membered di-or triaza diunsaturated ring)carbonyl guanidine derivateives for the treatment of ischemia |
09/08/2004 | EP1453817A1 Thiazole derivatives with fungicidal activity |
09/08/2004 | EP1453810A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
09/08/2004 | EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
09/08/2004 | EP1453515A2 Method to treat cystic fibrosis |
09/08/2004 | EP1345603A4 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
09/08/2004 | EP1289972B1 Serine protease inhibitors |
09/08/2004 | EP1289950B1 Serine protease inhibitors |
09/08/2004 | EP1165505B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
09/08/2004 | EP1084114B1 Isothiazole derivatives useful as anticancer agents |
09/08/2004 | EP1047678B1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
09/08/2004 | EP0623126B1 Imidazole derivatives and their use as cytokine inhibitors |
09/08/2004 | CN1527830A Ether derivatives useful as inhibitors of PDE4 isozymes |
09/08/2004 | CN1527828A 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
09/08/2004 | CN1527827A Therapeutic heterocyclic compounds |
09/08/2004 | CN1527819A Novel heterocyclic compound and medicinal use thereof |
09/08/2004 | CN1527818A 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
09/08/2004 | CN1527709A Therapeutic combinations for cardiovascular and inflammatory indications |
09/08/2004 | CN1165534C Heterocyclyl amino methyloxazolidinones as antibacterials |
09/08/2004 | CN1165532C Substituted 3-cyanoquinolines as protein tyrosine kinase inhibitors |
09/07/2004 | US6787652 Lowering lipids and serum cholesterol without generating adverse cardiac effects; 4,5-dihydro-3,5-dioxo-1,2,4-triazine derivatives |
09/07/2004 | US6787651 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agents |
09/07/2004 | US6787561 Benzimidazole compounds |
09/07/2004 | US6787551 Thiazolidinedione derivatives and pharmaceutical composition comprising the same |
09/07/2004 | US6787540 Compounds useful as reversible inhibitors of cysteine proteases |
09/07/2004 | US6787534 Sulfonamide-containing heterocyclic compounds |
09/02/2004 | WO2004074283A1 N-heterocyclyl-substituted amino-thiazole derivatives as protein kinase inhibitors |
09/02/2004 | WO2004074280A1 Pyridine derivatives as fungicidal compounds |
09/02/2004 | WO2004074274A1 Substituted n-aryl nitrogen heterocycles |
09/02/2004 | WO2004074270A2 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
09/02/2004 | WO2004074218A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
09/02/2004 | WO2004058730A3 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
09/02/2004 | WO2004052313A3 Anti-infectives |
09/02/2004 | WO2004050036A3 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents |
09/02/2004 | WO2004049797A3 Pesticidal sulphonylaminopyrazoles |
09/02/2004 | WO2004035569A3 Novel compounds with antibacterial activity |
09/02/2004 | WO2004014851A3 Tyrosine kinase inhibitors |
09/02/2004 | WO2003099786A3 Aromatic sulfones and their medical use |
09/02/2004 | US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
09/02/2004 | US20040171848 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
09/02/2004 | US20040171842 VIRICIDES; uSING A SECONDARY AMIDE COMPOUNDAIDS |
09/02/2004 | US20040171835 Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient |
09/02/2004 | US20040171644 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
09/02/2004 | US20040171643 Acylaminothiazole derivatives, their preparation and therapeutic use |
09/02/2004 | US20040171641 Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP) |
09/02/2004 | US20040171638 Chemokine receptor binding heterocyclic compounds |
09/02/2004 | US20040171626 having good to very good inhibitory activity against HCV polymerase; hepatitis C virus |
09/02/2004 | US20040171620 Nitrogen-containing bicyclic heterocycles for use as antibacterials |
09/02/2004 | US20040171614 Novel gamma secretase inhibitors |
09/02/2004 | US20040171611 crystal modification of an active substance is important to the reproducible active substance content of a preparation |
09/02/2004 | US20040171606 antagonism/inhibition, of the D3 receptor; substance abuse. |
09/02/2004 | US20040171604 strong antithrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses |
09/02/2004 | US20040171543 Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
09/02/2004 | US20040171520 Melanocortin receptor-specific peptidomimetics |
09/02/2004 | US20040171490 Preventing infestation of plants by phytopathogenic microorganisms; horticulture, agriculture |
09/02/2004 | US20040171099 Using luciferin derivatives for analyzing metabolic activity in animals, cells or in cell-free reaction formulations |
09/02/2004 | US20040171075 Modulation of protein functionalities |
09/02/2004 | DE10307845A1 Heterocyclische Amide, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel Heterocyclic amides, processes for their preparation, compositions containing them and their use as pesticides |
09/02/2004 | DE10307142A1 Substituierte N-Aryl-Stickstoffheterocyclen Substituted N-aryl nitrogen heterocycles |
09/02/2004 | CA2516590A1 Substituted n-aryl nitrogen heterocycles |
09/02/2004 | CA2516235A1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
09/02/2004 | CA2516234A1 N-heterocyclyl-substituted amino-thiazole derivatives as protein kinase inhibitors |
09/02/2004 | CA2514862A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
09/01/2004 | EP1452530A1 Azole compound and medicinal use thereof |
09/01/2004 | EP1452525A1 Amide derivatives and drugs |
09/01/2004 | EP1452524A1 "2-oxo-1-pyrrolidine derivative and its pharmaceutical uses" |
09/01/2004 | EP1452522A2 Novel compounds and compositions as protease inhibitors |
09/01/2004 | EP1452521A1 Cyclic compound and ppar agonist |
09/01/2004 | EP1451185A1 Indole-2-carboxamides as factor xa inhibitors |
09/01/2004 | EP1451175A1 Thrombin inhibitors |
09/01/2004 | EP1451172A1 Therapeutic isoquinoline compounds |
09/01/2004 | EP1451165A1 Substituted benzoxazoles and analogues as estrogenic agents |
09/01/2004 | EP1451164A2 Amide derivatives having improved solubility |
09/01/2004 | EP1451160A2 Pyrazole-amides and-sulfonamides |
09/01/2004 | EP1451158A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties |
09/01/2004 | EP1451157A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties |
09/01/2004 | EP1451154A2 Inhibitors of cytosolic phospholipase a2 |
09/01/2004 | EP1450901A2 (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase |
09/01/2004 | EP1450801A2 2-aminoquinoline compounds |
09/01/2004 | EP1450797A1 Benzothiazole derivatives |
09/01/2004 | EP1450796A1 Benzothiazole derivatives |
09/01/2004 | EP1450794A1 Novel dipeptidyl peptidase iv (dp-iv) inhibitors as anti-diabetic agents |
09/01/2004 | EP1450792A1 Benzazole derivatives for the treatment of scleroderma |
09/01/2004 | EP1450791A1 Hydrazonopyrazole derivatives and their use as therapeutics |
09/01/2004 | EP1450750A2 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
09/01/2004 | EP1292594B1 Quinazoline derivatives for the treatment of tumours |
09/01/2004 | EP1237889B1 Antibiotic sultam and sultone derived oxazolidinones |
09/01/2004 | EP1165528B1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
09/01/2004 | EP0944623B1 Substituted pyrazole-3-yl benzazoles |
09/01/2004 | CN1525971A Substituted benzo-nitro-heterocycles |